Pfizer Inc.
Tubulysin analogs and methods for their preparation

Abstract:

The present invention is directed to novel cytotoxic tubulysin analogs and derivatives, to antibody drug conjugates thereof, and to methods for using the same to treat medical conditions including cancer.